← Back

Wire · opportunities

Coreline Soft Receives U.S. FDA 510(k) Clearance for AVIEW Aorta Metrics, Expanding Its ...

Published

23 October 2026

Topic

opportunities

◆ Sectors

Healthtech Infrastructure

◆ Geography

United States

◆ Source

Read at orthospinenews.com →

◆ Verified

Fusion42 · 23 October 2026 · Fusion42 review

Coreline Soft has received FDA 510(k) clearance for AVIEW Aorta Metrics, expanding its AI-powered chest CT imaging analysis capabilities in the U.S. The software enables automated aorta segmentation and quantitative diameter measurement, supporting cardiovascular assessment alongside existing pulmonary disease tools.

This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure, and 2 sources have reported it between 19 Oct 2026 and 23 Oct 2026.

◆ ◆ The Wire takeaway

Your chance to sell cardiovascular AI in US hospitals just grew. Coreline Soft’s clearance shows the market openness for integrated CT analysis tools beyond lungs.

◆ Coverage

2 sources · first reported 19 Oct 2026 · latest 23 Oct 2026

◆ Related on Wire

◆ Topics

Healthtech Infrastructurefda-clearancemedical-imagingai-healthtechcardiovascularchest-ct